Looking towards the future of psychedelics for mental illness

The chapter explores the potential paradigm shift in psychiatry through the upcoming wave of research in psychedelics and MDMA. It discusses the interest in creating novel derivatives of psychedelics for commercial advantage and Professor David Nutt's curiosity in understanding the therapeutic differences of MDMA from drugs like methamphetamine.